Gail Berman

681 total citations
7 papers, 476 citations indexed

About

Gail Berman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Gail Berman has authored 7 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 1 paper in Infectious Diseases. Recurrent topics in Gail Berman's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Lipoproteins and Cardiovascular Health (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Gail Berman is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Lipoproteins and Cardiovascular Health (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper). Gail Berman collaborates with scholars based in United States, Australia and Belgium. Gail Berman's co-authors include Enrico P. Veltri, John Strony, Lisa K. Jennings, Jinglan Pei, David J. Moliterno, Karen S. Pieper, Khaled M. Ziada, Pamela S. Douglas, Frans Van de Werf and Diane Joseph‐McCarthy and has published in prestigious journals such as The Lancet, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Gail Berman

7 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gail Berman United States 6 398 132 131 124 37 7 476
Herm Jan M. Brinkman Netherlands 12 225 0.6× 165 1.3× 74 0.6× 174 1.4× 34 0.9× 18 471
Tomoya Hara Japan 9 176 0.4× 100 0.8× 68 0.5× 60 0.5× 49 1.3× 21 364
Karsten Schrör Germany 4 273 0.7× 112 0.8× 131 1.0× 86 0.7× 27 0.7× 4 417
James H. Chesebro United States 6 222 0.6× 52 0.4× 128 1.0× 45 0.4× 34 0.9× 8 349
James A. Szalony United States 8 180 0.5× 209 1.6× 96 0.7× 75 0.6× 19 0.5× 10 372
J. H. Chesebro United States 7 168 0.4× 79 0.6× 97 0.7× 61 0.5× 28 0.8× 13 243
Daniel Isaza Colombia 7 308 0.8× 31 0.2× 231 1.8× 72 0.6× 20 0.5× 19 427
GG Nenci Italy 8 137 0.3× 86 0.7× 128 1.0× 82 0.7× 67 1.8× 18 328
Juan Gaztañaga United States 9 217 0.5× 35 0.3× 54 0.4× 81 0.7× 34 0.9× 18 325
Tomohiro Sakamoto Japan 10 170 0.4× 34 0.3× 87 0.7× 39 0.3× 27 0.7× 11 370

Countries citing papers authored by Gail Berman

Since Specialization
Citations

This map shows the geographic impact of Gail Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail Berman more than expected).

Fields of papers citing papers by Gail Berman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail Berman. The network helps show where Gail Berman may publish in the future.

Co-authorship network of co-authors of Gail Berman

This figure shows the co-authorship network connecting the top 25 collaborators of Gail Berman. A scholar is included among the top collaborators of Gail Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail Berman. Gail Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
2.
Kalaycı, Arzu, C. Michael Gibson, Paul M. Ridker, et al.. (2022). ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future. Current Atherosclerosis Reports. 24(7). 585–597. 22 indexed citations
4.
Becker, Richard C., David J. Moliterno, Lisa K. Jennings, et al.. (2009). Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. The Lancet. 373(9667). 919–928. 222 indexed citations
5.
Bove, A. A., et al.. (2005). Factors Affecting Survival After Heart Transplantation: Comparison of Pre- and Post-1999 Listing Protocols. The Journal of Heart and Lung Transplantation. 25(1). 42–47. 12 indexed citations
6.
Berman, Gail, et al.. (1990). Effects of sample volume location, imaging view, heart rate and age on tricuspid velocimetry in normal subjects. The American Journal of Cardiology. 65(15). 1026–1030. 30 indexed citations
7.
Douglas, Pamela S., Gail Berman, Mary L. OʼToole, W. Douglas B. Hiller, & Nathaniel Reichek. (1989). Prevalence of multivalvular regurgitation in athletes. The American Journal of Cardiology. 64(3). 209–212. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026